期刊文献+

内科综合性治疗肝硬化难治性腹水的临床疗效观察 被引量:2

原文传递
导出
摘要 腹水是肝硬化常见的并发症,约90%的腹水患者对标准的内科治疗有良好反应,随着腹水的反复发作,其对利尿剂的敏感性逐渐减弱,大约10%的腹水患者对利尿剂的反应不佳,即为难治性腹水[1].我院用内科综合治疗了36例难治性腹水,取得较好疗效,现报告如下.
出处 《中国基层医药》 CAS 2010年第24期3385-3385,共1页 Chinese Journal of Primary Medicine and Pharmacy
  • 相关文献

参考文献10

  • 1中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 2辛建锋.肝硬化难治性腹水28例[J].第四军医大学学报,2007,28(17):1582-1582. 被引量:12
  • 3曾欣,林勇,谢渭芬.肝硬化腹水的处理[J].中华消化杂志,2005,25(12):757-759. 被引量:57
  • 4Planas R,Montoliu S,Balleste B,et al.Natural history of patients hospitalized for management of cirrhotic ascites.Clin Gastroenterol Hepatol,2006,4(11):1385 -1394.
  • 5Gines P,Wong F,Watson H,et al.Effects of satavaptan,a selective vasopressin V2 receptor antagonist,on ascites and serum sodium concentration in patients with cirrhosis and hyponatremia.Hepatology,2008,48(1):204-213.
  • 6Pache I,Bilodeau M.Severe hemorrhage following abdominal paracentesis for ascites in patients with liver disease.Aliment Pharmacol Ther,2005,21 (5):525-529.
  • 7张锦前,杨玉英,吴亮,罗凌,赫嵘,蒋煜,刘庄.肝硬化合并自发性细菌性腹膜炎临床诊断标准及其病原菌分析[J].中国医师进修杂志(内科版),2006,29(4):47-49. 被引量:9
  • 8Bernardi M.Optimum use of diuretics in managing ascites in patients with cirrhosis.Gut,2010,59(1):10-11.
  • 9Angeli P,Fasolato S,Mazza E,et al.Combined versus sequential diuretic treatment of ascites in nonazotemic patients with cirrhosis:results of an open randomized clinical trial.Gut,2010,59(1):98-104.
  • 10Moreau R,Valla DC,Durand-Zaleski I,et al.Comparison of outcome in patients with cirrhosis and,ascites following treatment with albumin or a synthetic colloid:a randomised controlled pilot trail.Liver Int,2006,26(1),46-54.

二级参考文献16

  • 1曾欣,林勇,谢渭芬.肝硬化腹水的处理[J].中华消化杂志,2005,25(12):757-759. 被引量:57
  • 2Moore KP,Wong F,Gines P,et al.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club.Hepatology,2003,38:258-266.
  • 3Gines P,Cardenas A,Arroyo V,et al.Management of cirrhosis and ascites.N Engl J Med,2004,350:1646-1654.
  • 4Gadano A,Moreau R,Vachiery F,et al.Natriuretic response to the combination of atrial natriuretic peptide and terlipressin inpatients with cirrhosis and refractory ascites.J Hepatol,1997,26:1229-1234.
  • 5Costello-Boerrigter LC,Boerrigter G,Burnett JC Jr.Revisiting salt and water retention:new diuretics,aquaretics,and natriuretics.Med Clin NorthAm,2003,87:475-491.
  • 6Janicic N,Verbalis JG.Evaluation and management of hypoosmolality in hospitalized patients.Endocrinol Metab Clin North Am,2003,32:459-481,vii.
  • 7Serradeil-Le Gal C.An overview of SR121463,a selective nonpeptide vasopressin V(2) receptor antagonist.Cardiovasc Drug Rev,2001,19:201-214.
  • 8Boger TD.Transjugular intrahepatic portosystemic shunt:current status.Gastroenterology,2003,124:1700-1710.
  • 9Salerno F,Merli M,Riggio O,et al.Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.Hepatology,2004,40:629-635.
  • 10Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis, report on the consensus conference of the International Ascites Club. Hepatology, 2003, 38: 258-266.

共引文献14074

同被引文献19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部